$LGND Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in LIGAND PHARMACEUTICALS INC. Get notifications about new insider transactions in LIGAND PHARMACEUTICALS INC for free.

Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 15 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 11 2015	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	President & CEO	Option Exercise	A	56.26	56,198	3,161,699	56,198
Feb 11 2015	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	President & CEO	Grant	A	0.00	15,945	0	136,044	120.1 K to 136 K (+13.28 %)
Jan 05 2015	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	P	45.23	126	5,699	27,433	27.3 K to 27.4 K (+0.46 %)
Jan 05 2015	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	EVP and COO	Buy	P	45.23	46	2,081	55,016	55 K to 55 K (+0.08 %)
Jan 05 2015	LGND	LIGAND PHARMACEUTI ...	Herman Melanie J	Director of Account ...	Buy	P	45.23	103	4,659	2,831	2.7 K to 2.8 K (+3.78 %)
Jan 05 2015	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Gift	G	0.00	3,283	0	57,412	60.7 K to 57.4 K (-5.41 %)
Nov 26 2014	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Gift	G	0.00	2,785	0	20,055	22.8 K to 20.1 K (-12.19 %)
Oct 15 2014	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Buy	P	45.68	2,000	91,360	49,286	47.3 K to 49.3 K (+4.23 %)
Oct 14 2014	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	EVP and COO	Option Exercise	M	9.97	1,000	9,970	132,056
Oct 14 2014	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	EVP and COO	Buy	M	9.97	1,000	9,970	54,970	54 K to 55 K (+1.85 %)
Oct 14 2014	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	EVP and COO	Buy	P	44.91	85	3,817	53,970	53.9 K to 54 K (+0.16 %)
Oct 10 2014	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Grant	A	43.12	2,000	86,230	23,697	21.7 K to 23.7 K (+9.22 %)
Oct 10 2014	LGND	LIGAND PHARMACEUTI ...	KNOTT DAVID M	Director	Grant	A	43.01	4,000	172,029	69,227	65.2 K to 69.2 K (+6.13 %)
Oct 09 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	P	42.99	11,000	472,890	255,716	244.7 K to 255.7 K (+4.50 %)
Oct 09 2014	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Option Exercise	M	8.58	2,500	21,450	0
Oct 09 2014	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Buy	M	8.58	2,500	21,450	47,286	44.8 K to 47.3 K (+5.58 %)
Oct 01 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	M	32.30	7,335	236,921	0
Oct 01 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	M	32.30	7,335	236,921	60,695	53.4 K to 60.7 K (+13.75 %)
Sep 29 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	M	17.88	2,500	44,700	0
Sep 29 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	M	12.53	7,335	91,908	0
Sep 29 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	M	10.12	7,335	74,230	0
Sep 29 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	M	8.58	2,500	21,450	0
Sep 29 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	M	6.82	630	4,297	0
Sep 29 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	M	10.12	7,335	74,230	53,360	46 K to 53.4 K (+15.94 %)
Sep 29 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	M	8.58	2,500	21,450	46,025	43.5 K to 46 K (+5.74 %)
Sep 29 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	M	17.88	2,500	44,700	43,525	41 K to 43.5 K (+6.09 %)
Sep 29 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	M	12.53	7,335	91,908	41,025	33.7 K to 41 K (+21.77 %)
Sep 29 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Buy	M	6.82	630	4,297	33,690	33.1 K to 33.7 K (+1.91 %)
Aug 15 2014	LGND	LIGAND PHARMACEUTI ...	HIGGINS JOHN L	President & CEO	Buy	P	54.97	1,000	54,970	120,099	119.1 K to 120.1 K (+0.84 %)
Jul 01 2014	LGND	LIGAND PHARMACEUTI ...	Herman Melanie J	Director of Account ...	Buy	P	43.79	98	4,292	2,728	2.6 K to 2.7 K (+3.73 %)
Jul 01 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	P	43.79	329	14,408	27,307	27 K to 27.3 K (+1.22 %)
Jul 01 2014	LGND	LIGAND PHARMACEUTI ...	FOEHR MATTHEW W	EVP and COO	Buy	P	43.79	428	18,743	53,885	53.5 K to 53.9 K (+0.80 %)
Jun 10 2014	LGND	LIGAND PHARMACEUTI ...	Herman Melanie J	Director of Account ...	Option Exercise	M	14.47	250	3,618	1,750
Jun 10 2014	LGND	LIGAND PHARMACEUTI ...	Herman Melanie J	Director of Account ...	Option Exercise	M	11.91	850	10,124	2,375
Jun 10 2014	LGND	LIGAND PHARMACEUTI ...	Herman Melanie J	Director of Account ...	Sell	S	69.68	250	17,420	2,630	2.9 K to 2.6 K (-8.68 %)
Jun 10 2014	LGND	LIGAND PHARMACEUTI ...	Herman Melanie J	Director of Account ...	Buy	M	14.47	250	3,618	2,880	2.6 K to 2.9 K (+9.51 %)
Jun 10 2014	LGND	LIGAND PHARMACEUTI ...	Herman Melanie J	Director of Account ...	Sell	S	69.68	850	59,228	2,630	3.5 K to 2.6 K (-24.43 %)
Jun 10 2014	LGND	LIGAND PHARMACEUTI ...	Herman Melanie J	Director of Account ...	Buy	M	11.91	850	10,124	3,480	2.6 K to 3.5 K (+32.32 %)
Jun 06 2014	LGND	LIGAND PHARMACEUTI ...	KNOTT DAVID M	Director	Option Exercise	A	67.53	3,312	223,659	3,312
Jun 06 2014	LGND	LIGAND PHARMACEUTI ...	KNOTT DAVID M	Director	Grant	A	0.00	1,484	0	65,227	63.7 K to 65.2 K (+2.33 %)
Jun 06 2014	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Option Exercise	A	67.53	3,312	223,659	7,335
Jun 06 2014	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Grant	A	0.00	1,151	0	21,697	20.5 K to 21.7 K (+5.60 %)
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	A	67.53	3,312	223,659	3,312
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Grant	A	0.00	333	0	22,840	22.5 K to 22.8 K (+1.48 %)
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Grant	A	0.00	1,151	0	22,507	21.4 K to 22.5 K (+5.39 %)
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Option Exercise	A	67.53	3,312	223,659	3,312
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Grant	A	0.00	666	0	33,060	32.4 K to 33.1 K (+2.06 %)
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Grant	A	0.00	1,151	0	32,394	31.2 K to 32.4 K (+3.68 %)
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Option Exercise	A	67.53	3,312	223,659	3,312
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Grant	A	0.00	666	0	34,353	33.7 K to 34.4 K (+1.98 %)
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Grant	A	0.00	1,151	0	33,687	32.5 K to 33.7 K (+3.54 %)
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Option Exercise	A	67.53	3,312	223,659	3,312
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Grant	A	0.00	666	0	44,786	44.1 K to 44.8 K (+1.51 %)
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	KOZARICH JOHN W	Director	Grant	A	0.00	1,151	0	44,120	43 K to 44.1 K (+2.68 %)
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Option Exercise	A	67.53	3,312	223,659	3,312
Jun 05 2014	LGND	LIGAND PHARMACEUTI ...	Patel Sunil	Director	Grant	A	0.00	1,151	0	41,691	40.5 K to 41.7 K (+2.84 %)
May 28 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	21.92	1,666	36,519	8,894
May 28 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	9.96	347	3,456	0
May 28 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	14.47	486	7,032	1,134
May 28 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	66.93	486	32,528	26,978	27.5 K to 27 K (-1.77 %)
May 28 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	14.47	486	7,032	27,464	27 K to 27.5 K (+1.80 %)
May 28 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	66.93	1,666	111,505	26,978	28.6 K to 27 K (-5.82 %)
May 28 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	21.92	1,666	36,519	28,644	27 K to 28.6 K (+6.18 %)
May 28 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	66.93	347	23,225	26,978	27.3 K to 27 K (-1.27 %)
May 28 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	9.96	347	3,456	27,325	27 K to 27.3 K (+1.29 %)
May 28 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	66.89	4,667	312,176	26,978	31.6 K to 27 K (-14.75 %)
Mar 26 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL		Sell	S	69.95	10,203	713,734	130,175	140.4 K to 130.2 K (-7.27 %)
Mar 26 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL		Sell	S	69.95	18,019	1,260,489	230,125	248.1 K to 230.1 K (-7.26 %)
Mar 26 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL		Sell	S	70.17	18,306	1,284,483	140,378	158.7 K to 140.4 K (-11.54 %)
Mar 26 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL		Sell	S	70.17	31,698	2,224,163	248,144	279.8 K to 248.1 K (-11.33 %)
Mar 20 2014	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Sell	S	79.63	5,000	398,147	32,536	37.5 K to 32.5 K (-13.32 %)
Mar 20 2014	LGND	LIGAND PHARMACEUTI ...	Davis Todd C	Director	Sell	S	79.45	2,500	198,637	37,536	40 K to 37.5 K (-6.24 %)
Mar 20 2014	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Option Exercise	M	8.97	5,000	44,850	0
Mar 20 2014	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Sell	S	78.83	5,000	394,150	21,356	26.4 K to 21.4 K (-18.97 %)
Mar 20 2014	LGND	LIGAND PHARMACEUTI ...	LAMATTINA JOHN L	Director	Buy	M	8.97	5,000	44,850	26,356	21.4 K to 26.4 K (+23.41 %)
Feb 28 2014	LGND	LIGAND PHARMACEUTI ...	Sabba Stephen L	Director	Sell	S	72.25	500	36,125	20,546	21 K to 20.5 K (-2.38 %)
Feb 21 2014	LGND	LIGAND PHARMACEUTI ...	KNOTT DAVID M	Director	Sell	S	72.97	900	65,676	1,843	2.7 K to 1.8 K (-32.81 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	73.05	5,359	391,464	79,390	84.7 K to 79.4 K (-6.32 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	73.05	112,369	8,208,319	1,685,344	1.8 M to 1.7 M (-6.25 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	73.05	10,557	771,167	158,684	169.2 K to 158.7 K (-6.24 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	73.05	18,615	1,359,787	279,842	298.5 K to 279.8 K (-6.24 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	73.03	2,771	202,375	84,749	87.5 K to 84.7 K (-3.17 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	73.03	57,370	4,189,920	1,797,713	1.9 M to 1.8 M (-3.09 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	73.03	5,395	394,015	169,241	174.6 K to 169.2 K (-3.09 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	73.03	9,464	691,187	298,457	307.9 K to 298.5 K (-3.07 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	74.66	14,003	1,045,409	87,520	101.5 K to 87.5 K (-13.79 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	74.66	153,751	11,478,450	1,855,083	2 M to 1.9 M (-7.65 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	74.66	16,331	1,219,209	174,636	191 K to 174.6 K (-8.55 %)
Feb 20 2014	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	74.66	16,915	1,262,808	307,921	324.8 K to 307.9 K (-5.21 %)
Feb 19 2014	LGND	LIGAND PHARMACEUTI ...	KNOTT DAVID M	Director	Sell	S	73.31	3,900	285,919	40,796	44.7 K to 40.8 K (-8.73 %)
Feb 19 2014	LGND	LIGAND PHARMACEUTI ...	KNOTT DAVID M	Director	Sell	S	73.31	11,531	845,368	233,361	244.9 K to 233.4 K (-4.71 %)
Feb 19 2014	LGND	LIGAND PHARMACEUTI ...	KNOTT DAVID M	Director	Sell	S	77.10	6,700	516,583	44,696	51.4 K to 44.7 K (-13.04 %)
Feb 19 2014	LGND	LIGAND PHARMACEUTI ...	KNOTT DAVID M	Director	Sell	S	77.10	19,769	1,524,229	244,892	264.7 K to 244.9 K (-7.47 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	78.87	9,500	749,265	244,716	254.2 K to 244.7 K (-3.74 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	77.43	6,700	518,779	254,216	260.9 K to 254.2 K (-2.57 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Aryeh Jason	Director	Sell	S	75.21	24,120	1,814,121	260,916	285 K to 260.9 K (-8.46 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	21.92	4,584	100,481	10,984
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	21.00	1,166	24,486	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	16.14	1,000	16,140	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	14.47	14,622	211,580	8,582
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	10.05	6,086	61,164	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	9.96	7,495	74,650	347
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	40.86	8,333	340,486	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	21.00	6,012	126,252	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	21.00	7,321	153,741	6,012
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	16.14	16,666	268,989	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	14.47	2,879	41,659	8,917
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Option Exercise	M	10.05	10,789	108,429	13,125
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	7,495	556,654	17,667	25.2 K to 17.7 K (-29.79 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	9.96	7,495	74,650	25,162	17.7 K to 25.2 K (+42.42 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	4,584	340,454	17,667	22.3 K to 17.7 K (-20.60 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	21.92	4,584	100,481	22,251	17.7 K to 22.3 K (+25.95 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	14,622	1,085,976	17,667	32.3 K to 17.7 K (-45.28 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	14.47	14,622	211,580	32,289	17.7 K to 32.3 K (+82.76 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	75.73	2,879	218,027	17,667	20.5 K to 17.7 K (-14.01 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	14.47	2,879	41,659	20,546	17.7 K to 20.5 K (+16.30 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	75.73	10,789	817,051	17,667	28.5 K to 17.7 K (-37.91 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	10.05	10,789	108,429	28,456	17.7 K to 28.5 K (+61.07 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	6,086	452,007	17,667	23.8 K to 17.7 K (-25.62 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	10.05	6,086	61,164	23,753	17.7 K to 23.8 K (+34.45 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	75.73	6,012	455,289	17,667	23.7 K to 17.7 K (-25.39 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	21.00	6,012	126,252	23,679	17.7 K to 23.7 K (+34.03 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	7,321	543,731	17,667	25 K to 17.7 K (-29.30 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	21.00	7,321	153,741	24,988	17.7 K to 25 K (+41.44 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	75.73	8,333	631,058	17,667	26 K to 17.7 K (-32.05 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	40.86	8,333	340,486	26,000	17.7 K to 26 K (+47.17 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	1,000	74,270	17,667	18.7 K to 17.7 K (-5.36 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	16.14	1,000	16,140	18,667	17.7 K to 18.7 K (+5.66 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	16,666	1,237,784	17,667	34.3 K to 17.7 K (-48.54 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	16.14	16,666	268,989	34,333	17.7 K to 34.3 K (+94.33 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Sell	S	74.27	1,166	86,599	17,667	18.8 K to 17.7 K (-6.19 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Sharp John P	VP Finance and CFO	Buy	M	21.00	1,166	24,486	18,833	17.7 K to 18.8 K (+6.60 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	21.92	4,584	100,481	10,560
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	21.00	1,166	24,486	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	16.14	1,000	16,140	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	10.05	4,779	48,029	0
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	9.96	1,736	17,291	347
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	14.47	2,000	28,940	13,130
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	A	74.42	20,000	1,488,400	20,000
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	42.90	386	16,559	4,947
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Option Exercise	M	14.47	1,230	17,798	1,620
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	14.47	2,000	28,940	31,645	29.6 K to 31.6 K (+6.75 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	9.96	1,736	17,291	29,645	27.9 K to 29.6 K (+6.22 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	74.50	1,736	129,332	27,909	29.6 K to 27.9 K (-5.86 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	74.50	1,230	91,635	29,645	30.9 K to 29.6 K (-3.98 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	14.47	1,230	17,798	30,875	29.6 K to 30.9 K (+4.15 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	74.50	4,779	356,036	29,645	34.4 K to 29.6 K (-13.88 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	10.05	4,779	48,029	34,424	29.6 K to 34.4 K (+16.12 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Sell	S	74.50	4,584	341,508	29,645	34.2 K to 29.6 K (-13.39 %)
Feb 14 2014	LGND	LIGAND PHARMACEUTI ...	Berkman Charles S	VP, Gen. Counsel & ...	Buy	M	21.92	4,584	100,481	34,229	29.6 K to 34.2 K (+15.46 %)

Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 15 next >